Screening colonoscopy is a powerful tool for prevention and early detection of colorectal cancer, but communication, program adherence, quality of screening and surveillance are essential. Poor communication between physicians and patients could jeopardize attendance at follow-up appointments. Steps should be taken to improve patients' understanding of the need for monitoring.
Colorectal cancer (CRC) screening with colonoscopy is a multistep process. Initial screening colonoscopy is only the first step, a very important step, but not an end unto itself. An effective CRC screening program needs a complete process, consisting of timely diagnosis, effective treatment and appropriate follow-up surveillance for people who have had an adenoma identified and removed, or a cancer detected and treated. Physicians must offer screening and patients need to accept their advice. Screening must be high quality and prompt, with appropriate surveillance and timely surgical referral if necessary (although most patients can be treated by complete removal of adenomas during colonoscopy). Insurers or health services need to ensure screening programs are financed. All these stages must work or screening programs will fail. 1 In a recent study, Sint Nicholaas and colleagues have demonstrated that patients often have suboptimal understanding of their colonoscopy results and the need for subsequent medical followup. 2 Polypectomy and postpolypectomy surveillance is one of the most powerful cancer prevention strategies in medicine if implemented with quality and continuity of follow-up, 3 and physicians are responsible for ensuring that patients fully understand their colonoscopy findings and the need for appropriate follow-up. The authors suggest several mechanisms (such as appointment reminder letters) that could help assure attendance at surveillance appointments. These mechanisms are similar to those that alert physicians to screen at-risk individuals who are already in the health-care system. Patients also have a responsibility for their own health care, to take preventive steps and attend follow-up appointments-most people change the oil in their car on a more regular basis than they plan health-care maintenance. Clear communication by health-care providers helps people to focus on health-care recommendations, such as CRC screening and surveillance. Unfortunately, most health-care systems do not reward physicians for spending unhurried time with patients.
The most common neoplastic findings in CRC screening are adenomas, and removing them has been shown to reduce CRC incidence and mortality when combined with follow-up surveillance. 3 However, the contributions of the initial polypectomy and the follow-up surveillance to these benefits are unclear. 4 Patients who have adenomas removed at their initial screening, particularly those with multiple adenomas (three or more), are at risk of developing additional metachronous adenomas. 1, 5 The risk of advanced adenomas in patients with a baseline adenoma is 3-12%, which is increased in patients who have a baseline advanced adenoma (and is also raised in men, further increasing with age). 5 A key principle in the recommendations for surveillance is risk stratification at baseline. People with only one or two tubular adenomas and no high-grade dysplasia are categorized as being at low risk of subsequent advanced adenomas, but those with large adenomas (≥1 cm) at baseline, villous features, high-grade dysplasia or three or more adenomas are categorized as being at high risk of subsequent adenomas. 5 Follow-up at 3 and 5 years is recommended for high and low-risk patients, respectively. If >10 adenomas are detected, genetic counseling and a shorter follow-up interval should be considered. 5 European guidelines recommend a 1-year follow-up time for the small group of patients who have five or more adenomas. 6 A considerable percentage of US gastroenterologists do not follow the guidelines well, both overutilizing and underutilizing colonoscopy. In one survey, around 25% of patients with no adenomas at baseline had a repeat colonoscopy within 5 years, and over 40% with small adenomas had one or more examinations within 5 years. About 40% of high-risk patients did not have surveillance within the recommended 3 years. Overutilization can be expensive and increase procedure-related risks, but underutilization leads to increased risk of cancer. Clinicians need to be better informed about the use of this procedure to maximize benefit and minimize complications. 7 Many metachronous adenomas are missed at baseline. 5, 8 A study comparing optical colonoscopy detection with CT colonography detection suggests that up to 17% of adenomas >1 cm are missed with optical colonoscopy. 9 Interval cancers are believed to primarily result from missed lesions or incompletely removed polyps, and 19-27% are found in the same anatomical area as prior polypectomies. 8 In patients who have had large sessile adenomas removed, 18% had residual adenomatous tissue. Thus, missed lesions and incomplete polypectomy are the major reasons for metachronous adenomas and interval cancers. High-quality baseline examinations, complete polypectomy and follow-up surveillance are all important to reduce the clinical effects of these lesions. 6, 8, 9 Quality indicators are critical predictors of interval cancers found at follow-up surveillance. The rate of interval cancers increases 11-fold when quality of screening colonoscopy is low, as measured by the adenoma detection rate (<20% overall adenomas detected in both sexes). Other important quality indicators are the rate of cecal intubation and the colonoscopy preparation state. Inadequate bowel preparation increases miss rates for adenomas and advanced adenomas by 35%. The withdrawal time, which was initially reported to be an important quality indicator, is now open to question. A meticulous examination, rather than time, seems to be the critical factor. the importance and timing of follow-up surveillance after removal of adenomas. Sint Nicolaas and colleagues have demonstrated the breakdown in communication that can occur between the endoscopist and the patient regarding follow-up surveillance after colonoscopic polypectomy: only 24% of patients who had an adenoma removed recalled this; only 79% recalled that surveillance was recommended, of whom 69% recalled the reason, and only 47% recalled the surveillance interval recommended. These results were obtained from a later survey and not in the immediate post procedure sedation recovery period. These deficiencies apparently did not affect attendance at surveillance examinations, but the authors carefully point out that the correlation could not be accurately assessed. Overall attendance at surveillance following colonoscopic polypectomy was 72%, which is low, but as the authors state, this might not be a precise figure. Interestingly, when a gastro enterologist explained findings and surveillance recommendations to the patient, recall was much better, demonstrating the central role of gastroenterologists in CRC screening with colonoscopy.
Physicians are strongly urged to base recommendations for appropriate surveillance on baseline risk stratification for the most efficient use of colonoscopy resources, thereby preventing unnecessary surveillance examinations. Resources can then be diverted to more frequent and timely screening for the general population. The first step in assuring that surveillance will be attended as recommended is to improve patients' awareness. Sint Nicolaas and colleagues find that this awareness might be suboptimal, and physicians and other health-care providers need to ensure that effective communication is achieved throughout the medical care continuum. This step will help to achieve our goal of preventing deaths from CRC.
